nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—TH—peripheral nervous system neoplasm	0.589	1	CbGaD
Tetrahydrobiopterin—NOS3—Doxorubicin—peripheral nervous system neoplasm	0.172	0.732	CbGbCtD
Tetrahydrobiopterin—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0317	0.135	CbGbCtD
Tetrahydrobiopterin—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0312	0.133	CbGbCtD
Tetrahydrobiopterin—NOS3—Effects of Nitric Oxide—MB—peripheral nervous system neoplasm	0.00865	0.14	CbGpPWpGaD
Tetrahydrobiopterin—TH—vagus nerve—peripheral nervous system neoplasm	0.00769	0.179	CbGeAlD
Tetrahydrobiopterin—TPH1—nerve—peripheral nervous system neoplasm	0.00631	0.146	CbGeAlD
Tetrahydrobiopterin—TPH1—ganglion—peripheral nervous system neoplasm	0.00623	0.145	CbGeAlD
Tetrahydrobiopterin—TH—cranial nerve—peripheral nervous system neoplasm	0.00586	0.136	CbGeAlD
Tetrahydrobiopterin—TH—pons—peripheral nervous system neoplasm	0.00579	0.134	CbGeAlD
Tetrahydrobiopterin—TH—Parkinsons Disease Pathway—PINK1—peripheral nervous system neoplasm	0.00517	0.0837	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.00379	0.0612	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Amine-derived hormones—TH—peripheral nervous system neoplasm	0.0036	0.0582	CbGpPWpGaD
Tetrahydrobiopterin—TH—nerve—peripheral nervous system neoplasm	0.003	0.0697	CbGeAlD
Tetrahydrobiopterin—TH—ganglion—peripheral nervous system neoplasm	0.00297	0.0688	CbGeAlD
Tetrahydrobiopterin—PAH—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.00277	0.0448	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—brainstem—peripheral nervous system neoplasm	0.00271	0.0629	CbGeAlD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00221	0.0357	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00161	0.0261	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Endothelin Pathways—COX2—peripheral nervous system neoplasm	0.00154	0.0249	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.00132	0.0213	CbGpPWpGaD
Tetrahydrobiopterin—TH—brainstem—peripheral nervous system neoplasm	0.00129	0.0299	CbGeAlD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—KNG1—peripheral nervous system neoplasm	0.00127	0.0206	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00127	0.0205	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.0011	0.0178	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Endothelin Pathways—GNAS—peripheral nervous system neoplasm	0.000655	0.0106	CbGpPWpGaD
Tetrahydrobiopterin—TH—cerebellum—peripheral nervous system neoplasm	0.000636	0.0148	CbGeAlD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000635	0.0103	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000582	0.00941	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—NTRK2—peripheral nervous system neoplasm	0.000558	0.00902	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFR1 specific signals—PTPN11—peripheral nervous system neoplasm	0.000505	0.00816	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.000501	0.0081	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—eNOS activation—AKT1—peripheral nervous system neoplasm	0.0005	0.00808	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000475	0.00768	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000474	0.00766	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000464	0.00751	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—NTRK1—peripheral nervous system neoplasm	0.000455	0.00735	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—COX2—peripheral nervous system neoplasm	0.000431	0.00697	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000425	0.00688	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000423	0.00683	CbGpPWpGaD
Tetrahydrobiopterin—TH—Parkinsons Disease Pathway—CASP3—peripheral nervous system neoplasm	0.000421	0.0068	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—BDNF—peripheral nervous system neoplasm	0.000416	0.00673	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—trigeminal ganglion—peripheral nervous system neoplasm	0.000415	0.00964	CbGeAlD
Tetrahydrobiopterin—NOS3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—peripheral nervous system neoplasm	0.000397	0.00642	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000391	0.00633	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00038	0.00614	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.000366	0.00592	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000365	0.0059	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000346	0.0056	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—peripheral nervous system neoplasm	0.000343	0.00555	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	0.000329	0.00532	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—PTPN11—peripheral nervous system neoplasm	0.000326	0.00528	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000297	0.00481	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—PTPN11—peripheral nervous system neoplasm	0.00029	0.00469	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.000288	0.00466	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000286	0.00463	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism of nitric oxide—AKT1—peripheral nervous system neoplasm	0.000275	0.00445	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000272	0.0044	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Isotretinoin—peripheral nervous system neoplasm	0.000268	0.00374	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000266	0.00371	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000266	0.00371	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.0037	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Epirubicin—peripheral nervous system neoplasm	0.000265	0.0037	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000264	0.00428	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Melphalan—peripheral nervous system neoplasm	0.000264	0.00369	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.000263	0.00368	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000263	0.00367	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000263	0.00366	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000262	0.00365	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.000261	0.00365	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.000261	0.00365	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00026	0.00362	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00026	0.00362	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000256	0.00358	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—PTPN11—peripheral nervous system neoplasm	0.000255	0.00413	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000253	0.00352	CcSEcCtD
Tetrahydrobiopterin—Infection—Topotecan—peripheral nervous system neoplasm	0.000251	0.0035	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000251	0.0035	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000251	0.0035	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Cisplatin—peripheral nervous system neoplasm	0.00025	0.00349	CcSEcCtD
Tetrahydrobiopterin—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000249	0.00347	CcSEcCtD
Tetrahydrobiopterin—Infection—Tretinoin—peripheral nervous system neoplasm	0.000249	0.00347	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Cisplatin—peripheral nervous system neoplasm	0.000249	0.00347	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000248	0.00346	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000247	0.00345	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000246	0.00343	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000246	0.00343	CcSEcCtD
Tetrahydrobiopterin—Infection—Melphalan—peripheral nervous system neoplasm	0.000246	0.00343	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000245	0.00342	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—AURKA—peripheral nervous system neoplasm	0.000245	0.00397	CbGpPWpGaD
Tetrahydrobiopterin—Cardiovascular disorder—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.00342	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.000244	0.0034	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000243	0.0034	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000243	0.0034	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000243	0.00392	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00024	0.00335	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000237	0.00383	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000236	0.00382	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.000235	0.00379	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.00325	CcSEcCtD
Tetrahydrobiopterin—Infestation—Etoposide—peripheral nervous system neoplasm	0.000232	0.00324	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.000232	0.00324	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000232	0.00324	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.00023	0.00372	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00023	0.00321	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.000229	0.0032	CcSEcCtD
Tetrahydrobiopterin—NOS3—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.000229	0.0037	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000228	0.00319	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000228	0.00319	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiogenesis—AKT1—peripheral nervous system neoplasm	0.000228	0.00369	CbGpPWpGaD
Tetrahydrobiopterin—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.000228	0.00318	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000225	0.00314	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000225	0.00364	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000222	0.0031	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000221	0.00308	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000221	0.00308	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000218	0.00304	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000218	0.00304	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000216	0.00302	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000216	0.00302	CcSEcCtD
Tetrahydrobiopterin—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.00298	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000213	0.00298	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000207	0.00288	CcSEcCtD
Tetrahydrobiopterin—Agitation—Vincristine—peripheral nervous system neoplasm	0.000206	0.00288	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000205	0.00286	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000205	0.00286	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000205	0.00286	CcSEcCtD
Tetrahydrobiopterin—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000203	0.00284	CcSEcCtD
Tetrahydrobiopterin—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.00283	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFR2 mediated vascular permeability—AKT1—peripheral nervous system neoplasm	0.000202	0.00326	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00281	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000202	0.00326	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.0002	0.00279	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.0002	0.00279	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000198	0.00277	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.00276	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000198	0.00276	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000198	0.00276	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000198	0.00276	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000198	0.00276	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.00275	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFR1 specific signals—AKT1—peripheral nervous system neoplasm	0.000196	0.00317	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000194	0.00271	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000193	0.00313	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—GNS—peripheral nervous system neoplasm	0.000191	0.00309	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	0.00019	0.00307	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00019	0.00265	CcSEcCtD
Tetrahydrobiopterin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.00263	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000188	0.00262	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—CASP3—peripheral nervous system neoplasm	0.000188	0.00303	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.0026	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.000187	0.00302	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.0026	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000186	0.0026	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000185	0.00258	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000185	0.00258	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.00257	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—NME1—peripheral nervous system neoplasm	0.000183	0.00296	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000183	0.00255	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000182	0.00254	CcSEcCtD
Tetrahydrobiopterin—Infection—Vincristine—peripheral nervous system neoplasm	0.000182	0.00254	CcSEcCtD
Tetrahydrobiopterin—PTGS2—cerebellum—peripheral nervous system neoplasm	0.000181	0.00421	CbGeAlD
Tetrahydrobiopterin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000179	0.0025	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—PTPN11—peripheral nervous system neoplasm	0.000178	0.00287	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—COX2—peripheral nervous system neoplasm	0.000176	0.00285	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—NRAS—peripheral nervous system neoplasm	0.000174	0.00282	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000173	0.0028	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.00241	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000173	0.00241	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000172	0.0024	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000171	0.00239	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000171	0.00239	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000169	0.00236	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000169	0.00236	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000168	0.00272	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—PTPN11—peripheral nervous system neoplasm	0.000168	0.00271	CbGpPWpGaD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000168	0.00234	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000167	0.00234	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.00233	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000167	0.00233	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—GNS—peripheral nervous system neoplasm	0.000167	0.0027	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000167	0.00233	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000166	0.00231	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000166	0.00231	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.000166	0.00268	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.00229	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.00226	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.00226	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000162	0.00226	CcSEcCtD
Tetrahydrobiopterin—Infection—Cisplatin—peripheral nervous system neoplasm	0.000161	0.00224	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000161	0.00224	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00016	0.00259	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000159	0.00222	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000159	0.00222	CcSEcCtD
Tetrahydrobiopterin—Rash—Topotecan—peripheral nervous system neoplasm	0.000159	0.00222	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000159	0.00222	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000159	0.00221	CcSEcCtD
Tetrahydrobiopterin—Cough—Etoposide—peripheral nervous system neoplasm	0.000158	0.00221	CcSEcCtD
Tetrahydrobiopterin—Headache—Topotecan—peripheral nervous system neoplasm	0.000158	0.00221	CcSEcCtD
Tetrahydrobiopterin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000158	0.0022	CcSEcCtD
Tetrahydrobiopterin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000158	0.0022	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000158	0.0022	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000158	0.0022	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000158	0.0022	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000157	0.0022	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000157	0.00219	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000157	0.00219	CcSEcCtD
Tetrahydrobiopterin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000157	0.00219	CcSEcCtD
Tetrahydrobiopterin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000157	0.00219	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.00218	CcSEcCtD
Tetrahydrobiopterin—Rash—Melphalan—peripheral nervous system neoplasm	0.000156	0.00218	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000156	0.00252	CbGpPWpGaD
Tetrahydrobiopterin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000156	0.00217	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.00217	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000154	0.00215	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000154	0.00214	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.000153	0.00248	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000152	0.00246	CbGpPWpGaD
Tetrahydrobiopterin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00211	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000151	0.00211	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.00209	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.00209	CcSEcCtD
Tetrahydrobiopterin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00015	0.00209	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00015	0.00209	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00209	CcSEcCtD
Tetrahydrobiopterin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000149	0.00208	CcSEcCtD
Tetrahydrobiopterin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000149	0.00208	CcSEcCtD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000149	0.0024	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000148	0.00207	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000147	0.00206	CcSEcCtD
Tetrahydrobiopterin—Infection—Etoposide—peripheral nervous system neoplasm	0.000147	0.00205	CcSEcCtD
Tetrahydrobiopterin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000147	0.00205	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000145	0.00202	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000145	0.00202	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000144	0.00201	CcSEcCtD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000144	0.00233	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00199	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00014	0.00196	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.00195	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00195	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—GNS—peripheral nervous system neoplasm	0.00014	0.00226	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00014	0.00195	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00193	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000137	0.00191	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000136	0.0022	CbGpPWpGaD
Tetrahydrobiopterin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00189	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000135	0.00188	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—NME1—peripheral nervous system neoplasm	0.000134	0.00217	CbGpPWpGaD
Tetrahydrobiopterin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00182	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00182	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00013	0.00182	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.00181	CcSEcCtD
Tetrahydrobiopterin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000129	0.0018	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—COX2—peripheral nervous system neoplasm	0.000129	0.00209	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000128	0.00179	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000128	0.00178	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—HRAS—peripheral nervous system neoplasm	0.000128	0.00206	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.000127	0.00206	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—AKT1—peripheral nervous system neoplasm	0.000127	0.00205	CbGpPWpGaD
Tetrahydrobiopterin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00177	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00176	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00175	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.00175	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000125	0.00175	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000124	0.002	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000122	0.0017	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000121	0.00169	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000121	0.00169	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.00168	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00168	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00168	CcSEcCtD
Tetrahydrobiopterin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.00167	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.00167	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000119	0.00166	CcSEcCtD
Tetrahydrobiopterin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000119	0.00166	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000117	0.00164	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000117	0.00164	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00164	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—PPP3R1—peripheral nervous system neoplasm	0.000117	0.00189	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000116	0.00162	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00162	CcSEcCtD
Tetrahydrobiopterin—NOS3—Thromboxane A2 receptor signaling—AKT1—peripheral nervous system neoplasm	0.000116	0.00187	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000116	0.00187	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Vincristine—peripheral nervous system neoplasm	0.000115	0.00161	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000115	0.00161	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00161	CcSEcCtD
Tetrahydrobiopterin—Headache—Vincristine—peripheral nervous system neoplasm	0.000115	0.0016	CcSEcCtD
Tetrahydrobiopterin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.00157	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000111	0.00154	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—GNS—peripheral nervous system neoplasm	0.00011	0.00178	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000109	0.00152	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000109	0.00152	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.0015	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—NRAS—peripheral nervous system neoplasm	0.000107	0.00173	CbGpPWpGaD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00149	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000105	0.00147	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000105	0.0017	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NME1—peripheral nervous system neoplasm	0.000105	0.0017	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.000104	0.00168	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000103	0.00144	CcSEcCtD
Tetrahydrobiopterin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000102	0.00142	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000102	0.00142	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00142	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	0.000102	0.00164	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000101	0.00142	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—COX2—peripheral nervous system neoplasm	0.000101	0.00164	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—ENO2—peripheral nervous system neoplasm	0.000101	0.00163	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—NRAS—peripheral nervous system neoplasm	0.000101	0.00163	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—ERBB2—peripheral nervous system neoplasm	0.000101	0.00163	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—peripheral nervous system neoplasm	9.92e-05	0.0016	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Etoposide—peripheral nervous system neoplasm	9.8e-05	0.00137	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—BCHE—peripheral nervous system neoplasm	9.79e-05	0.00158	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.75e-05	0.00136	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	9.67e-05	0.00156	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	9.65e-05	0.00156	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Cisplatin—peripheral nervous system neoplasm	9.61e-05	0.00134	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	9.58e-05	0.00155	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Etoposide—peripheral nervous system neoplasm	9.42e-05	0.00132	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.00131	CcSEcCtD
Tetrahydrobiopterin—Agitation—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.00131	CcSEcCtD
Tetrahydrobiopterin—Rash—Etoposide—peripheral nervous system neoplasm	9.34e-05	0.0013	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Etoposide—peripheral nervous system neoplasm	9.34e-05	0.0013	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.34e-05	0.00151	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Etoposide—peripheral nervous system neoplasm	9.28e-05	0.0013	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—TH—peripheral nervous system neoplasm	9.2e-05	0.00149	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	9.17e-05	0.00148	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—IFNB1—peripheral nervous system neoplasm	9.1e-05	0.00147	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—GNS—peripheral nervous system neoplasm	9.09e-05	0.00147	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.00124	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Epirubicin—peripheral nervous system neoplasm	8.82e-05	0.00123	CcSEcCtD
Tetrahydrobiopterin—Nausea—Etoposide—peripheral nervous system neoplasm	8.8e-05	0.00123	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	8.67e-05	0.00121	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.00121	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.0012	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	8.58e-05	0.00139	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ENO2—peripheral nervous system neoplasm	8.47e-05	0.00137	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KNG1—peripheral nervous system neoplasm	8.43e-05	0.00136	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.00116	CcSEcCtD
Tetrahydrobiopterin—Infection—Epirubicin—peripheral nervous system neoplasm	8.25e-05	0.00115	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—peripheral nervous system neoplasm	8.22e-05	0.00115	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	8.17e-05	0.00132	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	8.16e-05	0.00114	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—SLC2A1—peripheral nervous system neoplasm	8.15e-05	0.00132	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	8.15e-05	0.00114	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.00113	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.02e-05	0.00112	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	7.99e-05	0.00129	CbGpPWpGaD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	7.96e-05	0.00111	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	7.86e-05	0.00127	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—HRAS—peripheral nervous system neoplasm	7.81e-05	0.00126	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	7.79e-05	0.00126	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.00107	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.00107	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—GNS—peripheral nervous system neoplasm	7.61e-05	0.00123	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.00106	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	7.54e-05	0.00105	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—GNAS—peripheral nervous system neoplasm	7.51e-05	0.00121	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.00104	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—HRAS—peripheral nervous system neoplasm	7.38e-05	0.00119	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—GNAS—peripheral nervous system neoplasm	7.38e-05	0.00119	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.37e-05	0.00119	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	7.31e-05	0.00102	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—NME1—peripheral nervous system neoplasm	7.3e-05	0.00118	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	7.29e-05	0.00118	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.001	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	7.17e-05	0.00116	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—BCHE—peripheral nervous system neoplasm	7.16e-05	0.00116	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	7.12e-05	0.00115	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HGF—peripheral nervous system neoplasm	7.03e-05	0.00114	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—COX2—peripheral nervous system neoplasm	7.02e-05	0.00114	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7e-05	0.000977	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—AKT1—peripheral nervous system neoplasm	6.9e-05	0.00112	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.83e-05	0.0011	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000948	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000944	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—TH—peripheral nervous system neoplasm	6.73e-05	0.00109	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ENO2—peripheral nervous system neoplasm	6.65e-05	0.00108	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000926	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.57e-05	0.000917	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.57e-05	0.000917	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	6.56e-05	0.00106	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—AKT1—peripheral nervous system neoplasm	6.51e-05	0.00105	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	6.45e-05	0.00104	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.37e-05	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.36e-05	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PPP3R1—peripheral nervous system neoplasm	6.36e-05	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000877	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	6.28e-05	0.00102	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000854	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.1e-05	0.000986	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000848	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000848	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000793	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.00079	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—BCHE—peripheral nervous system neoplasm	5.62e-05	0.000909	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	5.61e-05	0.000907	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ENO2—peripheral nervous system neoplasm	5.51e-05	0.00089	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.000767	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—GNAS—peripheral nervous system neoplasm	5.49e-05	0.000888	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ABCB1—peripheral nervous system neoplasm	5.39e-05	0.000871	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.36e-05	0.000867	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	5.3e-05	0.000857	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000737	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.000734	CcSEcCtD
Tetrahydrobiopterin—Rash—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000731	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.00073	CcSEcCtD
Tetrahydrobiopterin—Headache—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000726	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—PTPN11—peripheral nervous system neoplasm	5.13e-05	0.000829	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000709	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	4.95e-05	0.000801	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	4.94e-05	0.000798	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000689	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000682	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000676	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000676	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.82e-05	0.00078	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	4.82e-05	0.000779	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000672	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—ENO2—peripheral nervous system neoplasm	4.61e-05	0.000746	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.000637	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—PTPN11—peripheral nervous system neoplasm	4.56e-05	0.000737	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.45e-05	0.00072	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SLC2A1—peripheral nervous system neoplasm	4.44e-05	0.000718	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GNAS—peripheral nervous system neoplasm	4.31e-05	0.000698	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.3e-05	0.000696	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ABCB1—peripheral nervous system neoplasm	4.23e-05	0.000684	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—BCHE—peripheral nervous system neoplasm	3.9e-05	0.00063	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	3.88e-05	0.000627	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	3.76e-05	0.000608	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.72e-05	0.000601	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GNS—peripheral nervous system neoplasm	3.72e-05	0.000601	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—TH—peripheral nervous system neoplasm	3.66e-05	0.000592	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.61e-05	0.000584	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—ERBB2—peripheral nervous system neoplasm	3.6e-05	0.000582	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.58e-05	0.000578	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.34e-05	0.000541	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.28e-05	0.00053	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	3.11e-05	0.000503	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	3.09e-05	0.0005	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—NRAS—peripheral nervous system neoplasm	3.08e-05	0.000498	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GNAS—peripheral nervous system neoplasm	2.99e-05	0.000484	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	2.98e-05	0.000482	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.93e-05	0.000474	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	2.87e-05	0.000464	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.86e-05	0.000462	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NRAS—peripheral nervous system neoplasm	2.74e-05	0.000443	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.72e-05	0.000441	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	2.6e-05	0.00042	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.56e-05	0.000414	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MYC—peripheral nervous system neoplasm	2.55e-05	0.000413	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.5e-05	0.000404	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTPN11—peripheral nervous system neoplasm	2.48e-05	0.000401	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—peripheral nervous system neoplasm	2.36e-05	0.000381	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—peripheral nervous system neoplasm	2.25e-05	0.000365	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	2.25e-05	0.000364	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.1e-05	0.00034	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—peripheral nervous system neoplasm	2.03e-05	0.000328	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—peripheral nervous system neoplasm	2e-05	0.000324	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—peripheral nervous system neoplasm	1.99e-05	0.000322	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB2—peripheral nervous system neoplasm	1.96e-05	0.000317	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	1.89e-05	0.000305	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	1.81e-05	0.000293	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.77e-05	0.000287	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—peripheral nervous system neoplasm	1.77e-05	0.000286	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.74e-05	0.000281	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	1.59e-05	0.000258	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.52e-05	0.000246	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	1.5e-05	0.000242	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NRAS—peripheral nervous system neoplasm	1.49e-05	0.000241	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—peripheral nervous system neoplasm	1.48e-05	0.00024	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—peripheral nervous system neoplasm	1.39e-05	0.000225	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.37e-05	0.000222	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.25e-05	0.000202	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	1.22e-05	0.000198	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.2e-05	0.000194	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—peripheral nervous system neoplasm	1.16e-05	0.000188	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—peripheral nervous system neoplasm	1.09e-05	0.000176	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.04e-05	0.000169	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	1.01e-05	0.000164	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.73e-06	0.000157	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—peripheral nervous system neoplasm	9.64e-06	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—peripheral nervous system neoplasm	8.07e-06	0.000131	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	8.02e-06	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.99e-06	0.000129	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.64e-06	0.000124	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.75e-06	0.000109	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	6.1e-06	9.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—peripheral nervous system neoplasm	5.68e-06	9.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	4.46e-06	7.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	3.94e-06	6.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	3.3e-06	5.34e-05	CbGpPWpGaD
